Search by Categories
- Insights
- Rare Disease
- Oncology
- Cell and Gene Therapy
- Medical Devices
- Consulting
- News & Analysis
- Therapeutic Areas
Our expertise in the industry
Valo Health receives USD 110 Million Series B from KochValo Health launched in September with USD 100 million and a couple of acquisitions under its belt to transform drug development and cut ...
Merck's Keytruda-Eisai's Lenvima Combo Make the Cut in Renal CancerNumerous immunotherapy-based combinations are already trying in the old game of gleek to stake up some share in previously un...
BASE10 Collaborates with DNA Link for COVID-19 Antibody Test ResearchUS-based BASE10 Genetics and Korean firm DNA Link announced a collaboration on a research project to appraise the usability...
The Gastroparesis market size in the 7MM was found to be USD 3,170.01 million in 2019 and is anticipated to increase at a CAGR for the study period 2017-2030 owing to dynamic pipeline therapies in...
The contribution of key pharma companies, such as 9 Meters Biopharma, ImmunogenX, Provention Bio, Cour Pharmaceuticals/Takeda, Precigen ActoBio, Falk Pharma, and Zedira is significant in driving C...
ImaginAb has collaborated with AstraZeneca, Pfizer and Takeda to develop technology to facilitate tumour imaging and monitoring inside the cells.ImaginAb is an emerging imaging company focuse...
FDA approves first Tenosynovial giant cell tumour treatment Turalio (Pexidartinib)The US FDA has given its approval to Turalio (pexidartinib) capsules for the treatment of symptomatic tenosyno...
Astellas’ Ophthalmology Innovation to Strengthen Further With Quethera AcquisitionAstellas has acquired Quethera, a gene therapy company headquartered in the UK, which is focused on developing...
Sutro Biopharma nets $85.4M to drive antibody-drug conjugates Sutro Biopharma reeled in an $85.4 million series E that will advance some early-stage programs as well as its cancer pipeline, which i...
Sanofi bags rights to Revolution’s SHP2 cancer drug Sanofi has paid $50 million to work with Revolution Medicines on the development of cancer drugs against SHP2. The partners plan to move small mo...
Human Immunodeficiency Virus or HIV is a species of Lentivirus (genus of retrovirus) th...
Progress is driven by innovation. When it comes to developing novel medications and the...
The HIV-1 treatment market for naïve and experienced patients is evolving consistently....
The Pharmaceuticals segment of the Healthcare Industry has a significant market across ...
Von Willebrand disease is a type of blood disorder that causes the blood to clot improp...
Hear from our subject-matter experts and in-house KOL’s on Pharma and Healthcare market trends.
